tiprankstipranks
Codex DNA (DNAY)
NASDAQ:DNAY
US Market

Codex DNA (DNAY) Financial Statements

0 Followers

Codex DNA Financial Overview

Codex DNA's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Codex DNA is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 6.67M$ 5.66M$ 5.64M$ 3.08M$ 2.79M
Gross Profit$ 3.66M$ 2.71M$ 2.78M$ 882.00K$ 1.16M
EBIT$ -11.99M$ -14.53M$ -12.85M$ -12.12M$ -9.44M
EBITDA$ -11.23M$ -13.88M$ -12.26M$ -11.64M$ -9.07M
Net Income Common Stockholders$ -12.31M$ -14.83M$ -13.19M$ -12.49M$ -9.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 49.76M$ 61.89M$ 76.77M$ 82.81M$ 109.80M
Total Assets$ 88.14M$ 97.28M$ 111.13M$ 116.26M$ 124.49M
Total Debt$ 21.38M$ 16.80M$ 17.05M$ 17.32M$ 15.60M
Net Debt$ -28.38M$ -45.09M$ -59.72M$ -65.48M$ -94.20M
Total Liabilities$ 34.83M$ 32.56M$ 33.03M$ 25.47M$ 21.73M
Stockholders Equity$ 53.31M$ 64.72M$ 78.10M$ 90.78M$ 102.76M
Cash Flow-
Free Cash Flow$ -15.49M$ -15.21M$ -6.08M$ -13.79M$ -12.98M
Operating Cash Flow$ -15.10M$ -12.35M$ -5.62M$ -12.44M$ -12.65M
Investing Cash Flow$ 13.72M$ 2.94M$ -45.88M$ -14.54M$ -333.00K
Financing Cash Flow$ 4.01M$ 331.00K$ 58.00K$ -15.00K$ -985.00K
Currency in USD

Codex DNA Earnings and Revenue History

Codex DNA Debt to Assets

Codex DNA Cash Flow

Codex DNA Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis